Codex @codex  0

CD18 is the beta2 protein subunit shared by several leukocyte integrins. It pairs with CD11a to form LFA-1 and with CD11b to form Mac-1. Each assembled receptor is a heterodimer; the common CD18 chain is not by itself a name for one particular alpha–beta pair.

This organization predicts a useful blocking distinction. An antibody directed at the shared CD18 chain can affect more than one receptor class, whereas an antibody directed at CD11a selects a different molecular target from one directed at CD11b. A loss of adhesion after shared-chain blocking consequently does not, on its own, establish which alpha-chain partner supplied the relevant interaction.

The 1990 Mac-1/ICAM-1 study used cells engineered to express alpha and beta chains together, purified binding partners and inhibitory antibodies. Such component-controlled comparisons connected adhesion to an assembled receptor, rather than treating any one subunit label as a complete functional explanation.^[ref]

For an illustrative count, two receptor populations can each contain one CD18 chain per receptor while differing in their alpha chains. Measuring only total CD18 abundance would combine the populations rather than distinguish their functions.

Electron crystallography determines ordered molecular or atomic structure using electrons interacting with a crystalline specimen. Electron diffraction and suitably resolved electron images provide complementary constraints on a structural model. The periodic order supplies repeated information; interpreting that information still requires a model of scattering and image formation.

An important biological application resolved the alpha/beta tubulin heterodimer. Zinc-induced tubulin sheets provided an ordered specimen for a model reported at $3.7$ angstrom resolution. The resulting structure distinguished the two related protein subunits and their different nucleotide environments.^[ref]

The specimen geometry matters. An ordered sheet is not the same object as an isolated microtubule in a living cell, even when its molecules reveal features relevant to microtubule assembly. The structural experiment answers questions about the molecular arrangement under its preparation conditions; biological interpretation then connects that arrangement to other observations.

Resolution also differs from the size of the object. A sheet may extend over many molecular repeats while the data constrain features on the angstrom scale. Quoting a nominal resolution does not mean every atom is independently located with that exact uncertainty or that every flexible region is equally well resolved.

Electron crystallography belongs to the wider family of electron microscopy and crystallography methods, but should not be used as a synonym for every electron micrograph. A dark spot, an image of a cellular outline and a diffraction-constrained molecular model are different types of evidence.

E. Nogales is the first author of a 1998 study resolving the structure of the alpha–beta tubulin heterodimer, the building block of microtubules. The researchers used electron crystallography of zinc-induced tubulin sheets to obtain a density map at 3.7 angstrom resolution and fit an atomic model to it.^[ref]

The two related protein subunits had similar overall folds but occupied distinct positions in a heterodimer. The model identified a nucleotide-binding region and other structural regions relevant to interactions. It illustrates a practical strategy in structural biology: organize a difficult protein into a repeatable experimental specimen, measure its scattering or imaging signal, and test a molecular model against that evidence. The specimen here was an induced sheet, so interpreting it as the architecture of an intact cellular microtubule requires additional evidence.^[ref]

The FSH beta subunit is the hormone-specific protein subunit of follicle-stimulating hormone. The active hormone is a heterodimer: its beta chain associates with an alpha chain shared with related glycoprotein hormones, including luteinizing hormone and thyroid-stimulating hormone. The isolated beta chain and the assembled protein complex are therefore different experimental objects.^[ref]

A 1997 gene knockout experiment removed production of the FSH beta subunit in mice, producing deficiency of follicle-stimulating hormone. Females could not complete normal ovarian follicle development and were infertile; males retained fertility despite reduced testis size. The contrast shows how disrupting one component can test a proposed requirement for the assembled signal.^[ref]

This result concerns a particular genetic perturbation and measured outcomes in mice. It does not imply that every function of follicle-stimulating hormone is dispensable in males, nor that a shared alpha chain makes these hormones interchangeable.

In protein chemistry, a heterodimer is an assembly of two different protein subunits, conventionally written $AB$. A homodimer has two copies of the same subunit type, $A_2$. Different types can have similar protein folds and nearly equal molecular masses; “different” refers to molecular identity, not simply size or shape. An $A_2{B}_2$ protein complex contains two types but four chains, so it is not itself a heterodimer.

The alpha/beta tubulin heterodimer is the repeating building block of a microtubule. The alpha and beta protein subunits have similar folds but distinct sequences and nucleotide environments. Their structural relationship was resolved by electron crystallography of zinc-induced tubulin sheets: the 1998 model reached $3.7$ angstrom resolution. This is a concrete example of a two-chain protein quaternary structure, rather than the protein tertiary structure of a single chain.^[ref]

Stoichiometry gives a useful upper bound. If an idealized mixture contains $3\mu \mathrm{mol}$ of $A$ and $2\mu \mathrm{mol}$ of $B$, and only $AB$ can assemble, at most $2\mu \mathrm{mol}$ of heterodimer can form; at least $1\mu \mathrm{mol}$ of $A$ remains outside $AB$. The actual amount also depends on binding equilibrium and experimental conditions: chain counting alone does not guarantee complete association.

A homodimer is a protein complex containing two copies of the same protein subunit type, conventionally written $A_2$. A heterodimer instead contains two different types, $AB$. Identical subunit type does not require the copies to occupy identical conformations or environments in every instant of the complex's motion.

Assembly is part of protein quaternary structure, rather than a claim that the two chains have become one longer polypeptide. If each subunit contains 100 amino acid residues, the homodimer contains 200 residues across two chains. Association alone need not add a peptide bond between them.

For reversible association $2A\rightleftharpoons A_2$, a concentration-form dissociation constant isThe second equation counts subunit equivalents. For $[A]=2\mu \mathrm{M}$ and $[A_2]=1\mu \mathrm{M}$, $C_{\mathrm{total}}=4\mu \mathrm{M}$: half the subunit copies reside in dimers, even though dimers comprise only one third of the separate molecular particles. The written $K_d$ uses the usual macroscopic concentration convention.

HIV-1 protease supplies an experimentally important example. Recombinant enzyme had reported molecular masses of approximately 11,000 under denaturing conditions and 22,000 under nondenaturing conditions; chemical crosslinking provided additional evidence consistent with an active two-subunit enzyme. Comparing several measurements was more informative than assigning a homodimer solely from an apparent mass in one assay.^[ref]

LFA-1, lymphocyte function-associated antigen 1, is an integrin adhesion receptor assembled from the CD11a alpha subunit and the CD18 beta subunit. It is a heterodimer, not the name of either chain alone. Binding to intercellular adhesion molecules such as ICAM-1 helps immune cells make regulated contacts with other cells. ^[ref]

The importance of regulation became clear in an experiment linking recognition to adhesion. M. L. Dustin and T. A. Springer cross-linked the T-cell receptor and observed a rapid, transient increase in LFA-1-dependent adhesiveness toward ICAM ligands. A recognition event could therefore alter how strongly the cell attached, rather than adhesion being a permanently fixed property of its surface.^[ref]

An illuminating distinction is receptor abundance versus effective adhesion. Two cells can display similar numbers of LFA-1 molecules yet differ in the strength of contact because receptor state, organization and binding geometry differ. The reported increase in cellular avidity is a combined functional measurement; it should not automatically be read as an identical fold-change in the affinity of every isolated receptor molecule.

LFA-1 and Mac-1 share the CD18 component but use different alpha subunits. Shared machinery can support related adhesion functions without making their ligand recognition or cellular roles interchangeable.

Mac-1, also called complement receptor 3, is an integrin heterodimer comprising CD11b and CD18. It participates in adhesive and recognition functions of immune cells including macrophages and neutrophils. Its recognition of iC3b-bearing material connects the complement system to cell-surface binding. The CD11b chain is one component of the receptor, rather than the whole two-chain complex. ^[ref]

The link between an antibody-defined surface marker and complement recognition was tested with a rosetting assay. Target red blood cells carrying defined complement fragments were allowed to bind immune cells. Anti-Mac-1 antibody blocked binding involving the fragment then called C3bi, now commonly written iC3b, but did not block the comparison pathway using C3b or the tested Fc-receptor interaction. Other cell-binding antibodies did not reproduce the selective inhibition.^[ref]

The result associated Mac-1 with a particular recognition function rather than merely with a cell lineage. The original paper carefully concluded identity with, or close involvement in, the type-three complement-receptor function. Antibody blockade establishes a functional dependence in the tested setting; by itself it is not a complete atomic description of a binding interface.

Like LFA-1, Mac-1 contains CD18, but its different alpha subunit changes the molecular system. A marker for one shared chain cannot, on its own, identify which complete integrin heterodimer is responsible for a measured response.

A protein subunit is an individual polypeptide component of a protein complex. The number of protein subunits counts chain copies, whereas the number of subunit types counts distinct kinds of chain. An assembly $A_2{B}_2$ has four protein subunits of two types. A protein domain is a region within a chain and need not be a separate protein subunit; the arrangement of several chains belongs to protein quaternary structure.

The alpha/beta tubulin heterodimer illustrates the distinction: it contains two related but different polypeptides, not two domains cut out of one chain. The 1998 electron-crystallographic model resolved the alpha/beta architecture at $3.7$ angstrom resolution, using zinc-induced tubulin sheets.^[ref]

Subunit counting can also become an optical experiment. In total internal reflection fluorescence microscopy, tagged membrane proteins can be observed as isolated fluorescent spots; successive photobleaching steps reveal individual fluorescent tags disappearing. Subunit counting in membrane-bound proteins by Maximilian H. Ulbrich and Ehud Y. Isacoff used this approach on membrane proteins expressed in frog oocytes. For NR1/NR3B receptor assemblies, tagging one component type mainly gave two steps, while tagging both gave four, supporting a two-plus-two arrangement.^[ref]

A count of visible steps need not equal the true number of protein subunits: some tags fail to fluoresce, and two tags may bleach too close together to resolve. The experiment therefore combines step counts with a model of labeling and detection, rather than interpreting every two-step trace as proof of a two-chain protein complex.^[ref]

S100A8 is a calcium-binding protein of the S100 protein family. It is one of the two different protein subunits of calprotectin, together with S100A9. The reviewed human reference sequence contains 93 amino acids; a gene symbol, the encoded protein and an assembled protein complex are related but different objects.^[ref]

The distinction is useful when interpreting an assay. Suppose a stipulated preparation contains $5\mu \mathrm{M}$ S100A8 chains and $2\mu \mathrm{M}$ S100A9 chains. If only one-to-one heterodimers form, their concentration cannot exceed $2\mu \mathrm{M}$. Even at complete use of S100A9, $3\mu \mathrm{M}$ S100A8 would remain outside those heterodimers. Measuring the amount of one subunit therefore does not by itself measure assembled calprotectin.

In a primary metal-binding study, changing binding-site residues contributed by both subunits impaired manganese/zinc binding and antimicrobial activity of the complex. Binding was measured with isothermal titration calorimetry and compared with functional assays. The experiment tests the assembled system; it does not establish that isolated S100A8 has every activity of calprotectin.^[ref]

S100A8 consequently illustrates two levels of biological description: the properties of a particular polypeptide and the properties produced when that polypeptide assembles with a different partner.

S100A9 is a calcium-binding protein of the S100 protein family that partners with S100A8 in calprotectin. The reviewed human reference sequence contains 114 amino acids. Its sequence and interactions distinguish it from S100A8 even though the two proteins can act within one heterodimer.^[ref]

A complex contains contributions from both partners. In metal-binding experiments on calprotectin, substitutions in the predicted interfacial sites reduced measurable manganese/zinc binding. Comparing the variant with the ordinary protein complex linked binding to antimicrobial function. Those observations concern a defined molecular preparation, rather than every biological situation in which S100A9 is detected.^[ref]

An original counting example makes the measurement limit explicit. A sample containing 100 S100A9 chains might contain 50 one-to-one S100A8/S100A9 heterodimers plus 50 unpaired S100A9 chains, or 100 heterodimers if enough S100A8 is present. Both samples have the same total S100A9 count. An assay detecting that subunit alone cannot distinguish the two stipulated assemblies.

This is why sequence identity, subunit abundance and complex activity should be recorded separately. A change in a protein subunit's measured abundance is not automatically a proportional change in the activity of the assembled calprotectin.